Effect of cerebral dopamine metabolism genetic polymorphism on patient-reported quality-of-life (QOL): An analysis of the E3805 CHAARTED trial.

Authors

Arjun Gupta

Arjun Gupta

University of Minnesota Masonic Cancer Center, Minneapolis, MN

Arjun Gupta , Yu-Hui Chen , Christopher Sweeney , David Frazier Jarrard , Elizabeth R. Plimack , Benjamin Adam Gartrell , Michael Anthony Carducci , Maha H. A. Hussain , Jorge A. Garcia , David Cella , Robert S. DiPaola , Alicia K. Morgans

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2023 ASCO Genitourinary Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session A: Prostate Cancer

Track

Prostate Cancer - Advanced,Prostate Cancer - Localized

Sub Track

Symptoms, Toxicities, Patient-Reported Outcomes, and Whole-Person Care

Clinical Trial Registration Number

NCT00309985

Citation

J Clin Oncol 41, 2023 (suppl 6; abstr 123)

DOI

10.1200/JCO.2023.41.6_suppl.123

Abstract #

123

Poster Bd #

D9

Abstract Disclosures